Halliburton (HAL)
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-09-04
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-09-04
Research Workspace
Put HAL beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Oil & Gas Equipment & Services is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 1% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMostly healthy — no soft spokes
Halliburton's growth depends on expanding international contract awards and integrated well delivery. Revenue growth remains strong, supported by recent earnings beats. It trades at 16× P/E versus a peer median of 31×, indicating it looks expensive on this basis. The risk lies in the fragile earnings quality, as reported profits are not well backed by cash. Peer multiples imply a price about 9% below where it trades. Our read remains intact.
Trailing returns as of 2026-09-04. HAL is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 28 analysts currently covering HAL (as of Sep 2026).
Based on 8 Wall Street analysts offering 12-month price targets for HAL in the last 4 months.
Continue this research
Compare HAL with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| HAL Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Oil & Gas Equipment & Services — fair value, gap to price, and forward P/E.
Compare the value case
Put HAL next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand international contract awards and integrated well delivery
Secures growth through international contract expansion.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $37.07
The last 12 months of price, then the range of analyst 12-month targets from today’s $37.07.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Expand international contract awards and integrated well delivery
New partnership expands international contract opportunities.
Advances: Launch and deploy new technologies
AI project aligns with technology deployment objectives.

Advances: Expand international contract awards and integrated well delivery
New deals enhance international contract awards and integrated delivery.
Advances: Focus on returns and capital discipline
Improved margins support capital discipline objective.

CEO's warning indicates potential headwinds for future performance.
Advances: Focus on returns and capital discipline
Higher revenue supports capital discipline and returns focus.
Advances: Launch new technologies
Improvement in activity suggests demand for new technologies.
